News | Ultrasound Imaging | April 19, 2017

GE Healthcare and Echosens Introduce Integrated Liver Package for Logiq S8 XDclear 2.0 Ultrasound

Combination of GE system’s Liver Package with Echosens’ FibroScan technology allows users to see and quantify liver disease in a single exam

GE Healthcare and Echosens Introduce Integrated Liver Package for Logiq S8 XDclear 2.0 Ultrasound

April 19, 2017 — To further support clinicians in their fight against chronic liver disease, Echosens and GE Healthcare have joined forces to offer a new integrated system, the Logiq S8 XDclear 2.0 ultrasound system, which will be presented at the International Liver Congress, April 19-23 in Amsterdam. Combining liver tissue quantification and ultrasound technologies, this platform provides a wider range of solutions for the screening, diagnosis and monitoring of liver diseases.

Chronic liver disease represents a major and rising public healthcare issue, affecting more than one billion people worldwide. It can be caused by a virus, such as hepatitis B or C, by excessive alcohol consumption or by dietary habits, resulting in conditions such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

These diseases generally remain symptomless and undetected until their very late stages but they progressively worsen over time and might ultimately lead to life-threatening complications, such as liver cirrhosis and liver cancer.

Echosens has developed FibroScan, the reference quantitative tool for the management of patients with chronic liver disease. FibroScan technology provides ultrafast and painless measurements of liver fibrosis, cirrhosis and steatosis, which are key parameters to assess liver condition. Recommended in the guidelines of prominent clinical organizations, including the World Health Organization (WHO), it has brought a non-invasive and cost-efficient alternative to painful liver biopsies, where a clinician inserts a needle into the liver to collect a tissue sample.

The Logiq S8 XDclear 2.0 is GE Healthcare's premium ultrasound system for a wide range of clinical uses. It offers a comprehensive Liver Package which, paired with FibroScan, now gives clinicians a powerful tool to see and quantify liver diseases in a single exam, supporting them with increased confidence and broader patient coverage.

The system may not be available in all regions.

For more information: www.gehealthcare.com, www.echosens.com

Related Content

Although it is likely that existing ultrasound systems will be repurposed to treat COVID-19 patients, growth is still expected as companies plan to ramp up production. The ultrasound systems market will therefore outpace other diagnostic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Leading data and analytics company GlobalData forecasts the market will reach $6bn by 2028, but increased usage due to COVID-19 is anticipated have a tangible effect.
News | Ultrasound Imaging | June 05, 2020
June 5, 2020 — Although it is likely that existing...
The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020
May 26, 2020  — Philips Healthcare recently received 510(k) clearance from the U.S.
An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020
May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 —Atrium Health is one of the first major health systems in the nation to put into wide practice a new...
Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

News | Focused Ultrasound Therapy | May 07, 2020
May 7, 2020 — University of Virginia researchers are pioneering the use of...
The new transducer reaches a 30% greater penetration, so clinicians have detailed images and performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps
News | Pediatric Imaging | May 06, 2020
May 6, 2020 — Philips announced the ...
Konica Minolta Healthcare's Rede Mini PACS are designed for specialty practices such as orthopedic, urgent care and family medicine clinics
News | PACS | April 28, 2020
April 28, 2020 – Konica Minolta Healthcare Americas released its Rede...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

News | Coronavirus (COVID-19) | April 24, 2020
April 24, 2020 — The Food and Drug Administration (FDA or the Agency) plays a critic